Rehmann Capital Advisory Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24,020
Closed -$307K 610
2024
Q4
$307K Buy
24,020
+11,520
+92% +$139K 0.02% 462
2024
Q3
$139K Sell
12,500
-1,300
-9% -$14.3K 0.01% 582
2024
Q2
$155K Buy
+13,800
New +$161K 0.01% 562

Other funds holding DVAX

Rehmann Capital Advisory Group's DVAX Position: Q1 2025 in Review

Rehmann Capital Advisory Group sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 24,020 shares — an estimated $307K sold.

Rehmann Capital Advisory Group first reported a position in DVAX in Q2 2024 and held it in 3 quarters. The position peaked at $307K in Q4 2024. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Rehmann Capital Advisory Group reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Rehmann Capital Advisory Group sold 24,020 Dynavax Technologies shares in Q1 2025, an estimated $307K.
  • Rehmann Capital Advisory Group first reported a position in Dynavax Technologies in Q2 2024 and held it in 3 quarters.
  • Rehmann Capital Advisory Group's Dynavax Technologies position peaked at $307K in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2025, filed 30 Apr 2025.